OMX Nordic 40
|
2 358,72
|
-16,88
|
-0,71 %
|
Analysen zu OMX Nordic 40-Werten
| 18.07.25 | ABB Sector Perform | RBC Capital Markets | |
| 18.07.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 17.07.25 | ABB Kaufen | DZ BANK | |
| 17.07.25 | Volvo AB Buy | UBS AG | |
| 17.07.25 | ABB Neutral | UBS AG | |
| 17.07.25 | Volvo AB Buy | Jefferies & Company Inc. | |
| 17.07.25 | Volvo AB Overweight | JP Morgan Chase & Co. | |
| 17.07.25 | Volvo AB Outperform | RBC Capital Markets | |
| 17.07.25 | ABB Underperform | Bernstein Research | |
| 17.07.25 | ABB Sector Perform | RBC Capital Markets | |
| 16.07.25 | Volvo AB Buy | Jefferies & Company Inc. | |
| 16.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 16.07.25 | Novo Nordisk Buy | UBS AG | |
| 15.07.25 | ABB Underweight | Barclays Capital | |
| 15.07.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.07.25 | AstraZeneca Buy | UBS AG | |
| 14.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.07.25 | Hennes & Mauritz AB Hold | Deutsche Bank AG | |
| 11.07.25 | Novo Nordisk Buy | UBS AG | |
| 09.07.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 09.07.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 09.07.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.07.25 | ABB Neutral | UBS AG | |
| 08.07.25 | Hennes & Mauritz AB Neutral | UBS AG | |
| 04.07.25 | AstraZeneca Buy | UBS AG | |
| 04.07.25 | Volvo AB Outperform | RBC Capital Markets | |
| 04.07.25 | ABB Sector Perform | RBC Capital Markets | |
| 03.07.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 03.07.25 | Nokia Underweight | Barclays Capital | |
| 03.07.25 | Nokia Market-Perform | Bernstein Research | |
| 03.07.25 | Novo Nordisk Buy | UBS AG | |
| 02.07.25 | ABB Neutral | Goldman Sachs Group Inc. | |
| 02.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.07.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 01.07.25 | Novo Nordisk Buy | UBS AG | |
| 01.07.25 | AstraZeneca Buy | UBS AG | |
| 30.06.25 | Hennes & Mauritz AB Equal Weight | Barclays Capital | |
| 30.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.06.25 | Novo Nordisk Buy | UBS AG | |
| 27.06.25 | Hennes & Mauritz AB Hold | Deutsche Bank AG |